US PTO Grants Pfizer Reissue Patent for Celebrex Caps, to Expire Dec. 2nd, 2015
Posted on March 05, 2013 at 09:02 AM EST
Pfizer Inc. (NYSE: PFE ) announced today that the United States Patent & Trademark Office has granted Pfizer a reissue patent (U.S. Patent No. RE44048), covering methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex^®. The reissue patent will expire on December 2, 2015, which includes six